FMC Corp (FMC) FinancialsFMCFMC Corp

FMC Corp (FMC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Insecticides, accounting for 48.8% of total sales, equivalent to $423.50M. Other significant revenue streams include Herbicides and Fungicides. Understanding this composition is critical for investors evaluating how FMC navigates market cycles within the Agricultural Chemicals industry.

Evaluating the bottom line, FMC Corp maintains a gross margin of 39.45%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 10.85%, while the net margin is -22.24%. These profitability ratios, combined with a Return on Equity (ROE) of -89.26%, provide a clear picture of how effectively FMC converts its operational activities into shareholder value.

In the context of the broader market, FMC competes directly with industry leaders such as LXU and ODC. With a market capitalization of $1.40B, it holds a leading position in the sector. When comparing efficiency, FMC's gross margin of 39.45% stands against LXU's 23.95% and ODC's 27.83%. Such benchmarking helps identify whether FMC Corp is trading at a premium or discount relative to its financial performance.

FMC Corp has reported significant losses, including a net income loss of $1.72 billion in Q4 2025 and a gross margin that has dropped to 39.45% in Q2 2026, down from 42.86% in Q4 2024. The company's total debt has risen to 257.70% of equity in Q2 2026, indicating increasing financial strain.